
51 - 200 employees
Founded 2007
๐ฅ Healthcare
๐ง Hardware
๐ฐ $42M Series D - Phagenesis on 2024-03
Healthcare โข Hardware
Phagenesis is a medical technology company that developed the Phagenyx System, a bedside neurostimulation device delivering pharyngeal electrical stimulation (PES) to restore swallowing function and accelerate recovery from post-stroke dysphagia. Supported by more than 30 publications and recent inclusion of PES in the American Heart Association/American Stroke Association guideline, Phagenyx is CE marked and has received FDA de novo classification for sale in the United States; it is intended for use in adult patients with neurogenic dysphagia and is used in hospitals and critical care settings to enable earlier oral nutrition and reduce aspiration risk, ICU time, and overall length of stay.
๐ฅ 10 minutes ago
Director responsible for global market access strategy and health economics for Phagenesis Ltd. Collaborating on reimbursement processes across the US, EU, UK, and Ireland markets.
๐ฌ๐ง United Kingdom โ Remote
๐ฐ $42M Series D - Phagenesis on 2024-03
โฐ Full Time
๐ด Lead
๐ Director